Hormone Replacement Therapy vs
These include a relative or absolute increase in glucagon secretion from alpha cells of the pancreas, elevated serum free fatty-acid concentrations, an impaired incretin effect (e.g., decreased secretion of glucagon-like peptide-1 [GLP-1]), enhanced renal reabsorption of glucose, and dysregulation of appetite control via decreased neurotransmitter response in the brain
doi: 10.1186/s13293-022-00471-x 151 YinLJYangYNLinXJWangXH
Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents
They are not interchangeable with GLP-1 medications, and the right choice depends on your health and goals
It also advises confirming the clinic runs baseline labs, maintains follow-up monitoring, and partners with licensed 503A compounding pharmacies for compounded options